The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review
Conclusion: Our analysis shows that the findings emerging from several clinical trials regarding the efficacy and safety of pharmacological intervention for COVID-19 might be jeopardized by the quality of control arms.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Azithromycin | Clinical Trials | COVID-19 | Drugs & Pharmacology | Hydroxychloroquine | Kaletra | Norvir | Study | Zithromax